Screener
Krystal Biotech, Inc. KRYS Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except par value) | March 31,2026 | December 31,2025 |
|---|---|---|
| Total assets | $1,396,967 | $1,333,794 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $4,089 | $3,238 |
| Current portion of lease liability | 1,800 | 1,771 |
| Accrued rebates | 70,717 | 58,181 |
| Accrued expenses and other current liabilities | 31,196 | 39,752 |
| Total current liabilities | 107,802 | 102,942 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s accounts payable?
- Krystal Biotech, Inc. (KRYS) reported accounts payable of $4.09M in Q1 2026.
- How has Krystal Biotech, Inc.'s accounts payable changed year-over-year?
- Krystal Biotech, Inc.'s accounts payable increased by 53.0% year-over-year, from $2.67M to $4.09M.
- What is the long-term trend for Krystal Biotech, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s accounts payable has grown at a 9.0% compound annual growth rate (CAGR), from $2.11M to $3.24M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Krystal Biotech, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude